Identity
- Trade Name
- NURO™ FDA UDI
- Generic Name
- Tibial nerve percutaneous incontinence-control electrical stimulation system FDA UDI
- Device Name
- ACCY 3533K THERAPY SESSION KIT FDA UDI
- Model / Reference
- 3533K FDA UDI
- Description
- ACCY 3533K THERAPY SESSION KIT FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00643169654631 FDA UDI
- 510(k) Number
- K132561 FDA UDI
- FDA Product Code
- NAM FDA UDI
- GMDN Term
- Tibial nerve percutaneous incontinence-control electrical stimulation system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 876.5310 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Tibial nerve percutaneous incontinence-control electrical stimulation system
Nuro™ by Medtronic, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Tibial nerve percutaneous incontinence-control electrical stimulation system.
- Urgent® PC Neuromodulation System — Uroplasty, LLC · Class II
- NURO™ — MEDTRONIC, INC. · Class II
- NURO™ — MEDTRONIC, INC. · Class II
Cleared under the same submission
K132561 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Medtronic, Inc.
Sources (1)
- FDA UDI da699672-df5e-4e29-90ed-16694391ccf0 36 fields · synced May 31, 2026